共查询到20条相似文献，搜索用时 609 毫秒
1.
有母源抗体雏鸡接种传染性法氏囊病疫苗的免疫效果研究 总被引：1，自引：0，他引：1
用两种中等毒力的IBDV致弱苗接种1～21日龄雏鸡,均受母源抗体干扰,导致不能引起免疫应答和产生免疫保护;接种用IBD病死鸡法氏囊制备的油乳剂灭活苗能有效地抵抗母源抗体干扰,使雏鸡产生免疫应答并获得保护。 相似文献
2.
给10头8周龄仔猪经口感染猪流行性腹泻肠管毒,于感染后5、15、25、35和45d各扑杀2头,采取胃及各段肠管标本,用免疫过氧化物酶技术(间接法)检查胃肠粘膜固有层中IgA、IgM和IgG产生细胞数;收集血液及胃、各段肠管分泌液,应用ELISA双抗体夹心法测定IgA、IgM和IgG含量。结果:实验猪感染后第15d,空肠下段、回肠和回盲口处粘膜固有层中IgA和IgM产生细胞明显增多,肠管分泌液中IgA含量与IgA产生细胞数呈正相关,肠道局部免疫反应的高峰比全身性(系统性)免疫出现得早,且周期短。本试验提示,肠道粘膜积极参与了该病的免疫过程;胃肠道对猪流行性腹泻病毒(PEDV)免疫反应的主要部位在空肠下段、回肠和回盲目;参与胃肠道免疫反应的免疫球蛋白产生细胞主要是IgA和IgM产生细胞。 相似文献
3.
4.
由于雏鸡新城疫母源抗体水平不一,对免疫程序安排存在不少问题,往往从雏鸡开始,需多次重复免疫,这样易造成免疫错乱,甚至造成部分鸡群免疫失败。据有关资料,认为用油乳剂灭能苗能弥补这一不足,並且对中鸡、产蛋鸡也可获得很高免疫水平,因此,国外早已有商品油乳剂苗,国内有的单位试用,作者对该苗的使用方法(包括单 相似文献
5.
6.
7.
鸭疫里默氏杆菌(Riemerella anatipestifer,RA)感染是主要危害2~8周龄雏鸭的高致病性细菌性传染病。为研制血清10型RA灭活油乳剂疫苗,选取10株血清10型RA分离株进行动物体复壮、分离和鉴定后,分别对部分毒株进行了毒力测定和灭活油乳剂疫苗的研制。结果表明,所有试验用分离株对7日龄雏鸭均具有较强的致病力。分离株YXL1和HXb2的半数致死量分别为2.8×108 cfu和82 cfu,不同菌株之间的毒力差异很大。用研制的灭活油乳剂疫苗对雏鸭进行2次免疫后,免疫鸭可获得高水平的特异性抗体,并可抵抗强毒RA的攻击,以HXb2免疫后的攻毒保护性最好。抗体水平检测和攻毒保护试验结果表明,用血清10型RA分离株HXb2制备的油乳剂灭活疫苗具有良好的免疫保护作用。 相似文献
8.
本文报道用鸡传染性法氏囊病（ＩＢＤ）油乳剂苗免疫种母鸡，产生抗体整齐，ＩＢＤ琼扩（ＡＧＰ）效价达２－５ｌｏｇ＾２，可防止雏鸡早期感染ＩＢＤ；对ＩＢＤ病毒严重污染地区或连年发生ＩＢＤ鸡场的２周龄以上雏鸡，应用ＩＢＤ油乳剂苗或ＩＢＤ油乳剂苗结合弱毒苗免疫，产生阳性率高，效果好；同时应用ＩＢＤ油乳剂苗与高免卵黄抗体，可用于防止同一鸡群重复发生ＩＢＤ。免疫方法上，改进以前的习惯用法，即首免用ＩＢＤ弱毒苗， 相似文献
9.
提取2株乳酸杆菌L.casei zhang和MG2-1的DNA作佐剂，按不同剂量添加到新城疫油乳剂灭活疫苗及禽流感（H5）亚型油乳剂灭活疫苗中。用上述2种加佐剂的油乳剂灭活疫苗对鸡进行免疲，每组20只，分别于15日龄和28日龄进行新城疫（ND）组和禽流感（AV）组首免，再分别于首免台2周加强免疫，在二免的第7天与第14天检测血清HI抗体水平。结果表明，与对照组相比，试验各组抗体水平达到显著或极显著水平，可提高抗体水平2^0.16～2^2.67。说明，2株乳酸杆菌DNA对新城疫油乳剂灭活疫苗和禽流感（H5）亚型油乳剂灭活疫苗具有免疫增强作用。 相似文献
10.
本研究采用ＡＧＰ、ＨＩ等试验方法，对经Ｈ９亚型禽流感油乳剂灭活苗免疫、免疫后攻毒以及经Ｈ９Ｎ２活毒人工感染后的ＳＰＦ鸡抗体产生、消长规律进行了测定，结果表明人工感染ＳＰＦ鸡和免疫鸡一周后，ＡＧＰ的检出率即可达到１００％；Ｈ９亚型禽流感油乳剂灭活苗自免疫后一周内即可产生ＨＩ抗体，２１－２８天达到高峰，并能对相同亚型病毒感染引发良好的免疫反应。 相似文献
11.
T G Kimman R A Brouwers F J Daus J T van Oirschot D van Zaane 《Veterinary immunology and immunopathology》1992,31(1-2):95-113
Enzyme-linked immunosorbent assays (ELISAs) for the detection of porcine IgM, IgA, IgG1 and IgG2 antibodies directed against Aujeszky's disease virus (ADV) are described. ADV-specific IgA and IgM were detected in an antibody capture assay, and ADV-specific IgG1 and IgG2 were detected in an indirect double antibody sandwich assay. A selected set of samples was tested in the four ELISAs and in a 24 h virus neutralization assay. Comparison of the results showed that the ELISAs were isotype-specific, sensitive, and reproducible. Samples with ADV antibody of one isotype showed that ADV-specific IgG1, IgG2 and IgM were able to neutralize the virus in vitro. In vitro neutralization of virus can be enhanced by complement. ADV-specific IgA neutralized virus only weakly. ADV-infected cells activated complement in the absence of antibody. Specific IgG2 and IgM enhanced complement activation. Analysis of the time course of antibody responses after infection or vaccination revealed that the isotype-specific ELISAs are suitable to study the humoral antibody response of pigs to the virus in mucosal secretions. Wild-type virus (strain NIA-3) and an attenuated vaccine strain (Bartha) administered intranasally induced mucosal IgM and IgA responses to the virus. In contrast, a killed vaccine (Nobivac) administered intramuscularly induced only weak mucosal IgM responses. The attenuated vaccine strain primed for a mucosal IgA memory response evoked upon challenge infection with wild-type virus. 相似文献
12.
Analysis of the quality of protection induced by a porcine influenza A vaccine to challenge with an H3N2 virus 总被引：3，自引：0，他引：3
Heinen PP van Nieuwstadt AP de Boer-Luijtze EA Bianchi AT 《Veterinary immunology and immunopathology》2001,82(1-2):39-56
Antigenic drift of swine influenza A (H3N2) viruses away from the human A/Port Chalmers/1/73 (H3N2) strain, used in current commercial swine influenza vaccines, has been demonstrated in The Netherlands and Belgium. Therefore, replacement of this human strain by a more recent swine H3N2 isolate has to be considered. In this study, the efficacy of a current commercial swine influenza vaccine to protect pigs against a recent Dutch field strain (A/Sw/Oedenrode/96) was assessed. To evaluate the level of protection induced by the vaccine it was compared with the optimal protection induced by a previous homologous infection. Development of fever, virus excretion, and viral transmission to unchallenged group mates were determined to evaluate protection. The vaccine appeared efficacious in the experiment because it was able to prevent fever and virus transmission to the unchallenged group mates. Nevertheless, the protection conferred by the vaccine was sub-optimal because vaccinated pigs excreted influenza virus for a short period of time after challenge, whereas naturally immune pigs appeared completely protected. The immune response was monitored, to investigate why the vaccine conferred a sub-optimal protection. The haemagglutination inhibiting and virus neutralising antibody responses in sera, the nucleoprotein-specific IgM, IgG, and IgA antibody responses in sera and nasal secretions and the influenza-specific lymphoproliferation responses in the blood were studied. Vaccinated pigs developed the same or higher serum haemagglutination inhibiting, virus neutralising, and nucleoprotein-specific IgG antibody titres as infected pigs but lower nasal IgA titres and lymphoproliferation responses. The lower mucosal and cell-mediated immune responses may explain why protection after vaccination was sub-optimal. 相似文献
13.
B cell and macrophage response in chicks after oral administration of Salmonella typhimurium strains 总被引：1，自引：0，他引：1
Despite the fact that, in a number of countries, vaccination programmes are extensively used to control Salmonella infection in poultry, information on the immune mechanisms, especially the cellular response, is still needed. The aim of the study was to characterise the B cell and macrophage response in caecum (IgA+, IgM+, IgG+ cells, macrophages), bursa of Fabricius (IgM+ cells, macrophages), and spleen (IgM+ cells) of chicks after oral administration of a non-attenuated Salmonella (S.) typhimurium wild-type strain (infection) or an attenuated commercial live S. typhimurium vaccine strain (immunisation) to day-old chicks as compared to non-treated control birds using immunohistochemistry and image analysis. In caecum, higher counts of IgM-secreting cells were detected in infected animals compared with the controls from day 5 until day 12 of age. In contrast, in treated groups, IgA-secreting cells were found in higher numbers only between day 8 and 12 of age. Infected birds showed a higher number of IgA+ cells in spleen and bursa of Fabricius compared to the controls. In the bursa of Fabricius of immunised and infected birds, a depletion of strongly stained IgM+ cells and macrophages was established between day 5 and 9 indicating a possibly special and independent role of this organ during the immunological reaction against Salmonella organisms. The results suggest that IgM- and IgA-secreting cells are of importance in the caecal immune response of chickens against Salmonella strains. Immunised chickens always showed a weaker immune reaction compared to infected animals. Present findings regarding the B cell reaction within avian caeca prove a participation of both humoral and cellular immunity in defence against Salmonella strains. Immunohistochemical examination of the cellular response (B cells and macrophages) in relevant organs of chickens may be an important tool to evaluate the immunogenic characteristics of potential Salmonella live vaccine candidates. 相似文献
14.
Four pregnant heifers were immunized by the intramammary route with killed or live Streptococcus agalactiae vaccine, and a 5th heifer was vaccinated by the intramuscular route with killed vaccine. Antibody in the colostrum from vaccinated and non-vaccinated glands was compared. Antibacterial glands was compared. Antibacterial antibody titers of the 4 immunoglobulin classes were determined by indirect fluorescent antibody assay. Although the content of immunoglobulin G1 (IgG1), IgG2, and IgM in the colostrum from the vaccinated glands was not substantially different from the nonvaccinated glands, IgA content was considerably greater in the former. Antibody specific to S agalactiae was isolated from all colostrum samples. The mouse passive protection test and Ouchterlony analysis were used to demonstrate the presence of type-specific antibody to Ia strain used for vaccination. The passive mouse protection test also was useful to compare the protective capacity of specific S agalactiae, type Ia, antibodies of immunoglobulin classes IgG, IgM, and IgA. Increased protective capacity of IgM and IgA over IgG1, on a weight basis, was demonstrated. The present study indicates that S agalactiae preparations, when introduced into the mammary gland, can give rise to local antibody synthesis in the vaccinated glands. 相似文献
15.
将１６只ＳＰＦ鸡分成４组，每组４只，分别接种新城疫油乳剂苗，新城疫、传染性支气管炎、传染性法氏囊病三联油乳剂苗，ＬａＳｏｔａ弱毒苗和Ｍｕｋｔｅｓｗｅｒ苗。接种后每隔２ｄ采血１次，用ＥＬＩＳＡ测定新城疫特异性ＩｇＭ和ＩｇＧ抗体。结果：油乳剂灭活苗接种组均无特异性ＩｇＭ抗体出现，特异性ＩｇＧ抗体高峰期出现在接种后２２ｄ，ＬａＳｏｔａ弱毒苗和Ｍｕｋｔｅｓｗｅｒ苗接种组均有特异性ＩｇＭ抗体出现，高峰期为接种后第９ｄ。各接种组经强毒攻击后，均出现ＩｇＭ反应，ＩｂＧ呈典型的回忆反应。进一步试验用ＬａＳｏｔａ灭活苗经肌肉、静脉接种和加氢氧化铝胶佐剂后肌肉接种，经测定，接种鸡均无或仅有很低水平的特异性ＩｇＭ抗体产生。 相似文献
16.
通过鲎素抗菌肽和超高静水压联合作用,制备出一种胸膜肺炎放线杆菌菌影。利用胸膜肺炎放线杆菌血清5型（CVCC263）制备菌影并检测其灭活率。CVCC263菌影疫苗接种免疫仔猪,二免14d后攻毒,每天测量体温,并观察精神状态,呼吸,食欲等。攻毒第8天对存活猪进行剖杀,测量肺部病变面积,进行病理检测。结果显示,免疫组抗体效价及血清中的IgG、IgM、IgA、IL-2、IL-4含量均较对照组显著增加。免疫组临床症状和肺部病变面积均小于对照组。CVCC263菌影疫苗免疫仔猪抗APP感染的保护效果是明显的,并且APP5型的菌影疫苗可对APP7型感染有交叉保护。 相似文献
17.
用Lasota系ND疫苗分别于10、20日龄进行点眼免疫后采用SLAB免疫组织化学对鸡哈氏腺在新新城疫（Newcastle Disease,ND)疫苗点眼免疫后IgA、IgM、IgG型浆细胞的数量变化及分布特征进行了研究。研究发现，Lasota系ND疫苗点眼免疫后鸡哈氏腺中（Harderian Gland,HG)中IgA、IgM、IgG型浆细胞的出现较对照组早，并于48日龄达到峰值，一免及二免后三种类型的浆细胞数量均极高于对照组（P＜0．01），其中IgA浆细胞的数量最多，IgM型浆细胞次之，IgG型浆细胞的数量最少。IgA、IgM、IgG三种浆细胞均散在分布于哈氏腺的间质中，且主要围绕各级管腔上皮及腺上皮分布，其中成熟的浆细胞紧贴腺上皮及管腔上皮分布。表明Lasonta系ND疫苗点眼免疫后可促进哈氏腺中的IgA、IgM、IgG型浆细胞的分化、成熟，这些浆细胞分泌的抗体成分可通过上皮而被分泌到管腔中去，最后到达泪液中，在眼区及上呼吸道起到保护作用。 相似文献
18.
We examined primary and memory isotype-specific antibody responses directed against pseudorabies virus in serum and mucosal fluids of pigs with and without passively acquired maternal antibody, and we studied the relationship between these responses and protection against virus challenge. Pigs were inoculated intranasally with the virulent NIA-3 strain or the avirulent Bartha strain, or they were inoculated IM with an inactivated vaccine containing the Phylaxia strain. Ten weeks later, all pigs were challenge-exposed intranasally with strain NIA-3. Only pigs that were without passively acquired antibody at the time they were inoculated with virulent virus appeared to have complete protective immunity against challenge exposure, as evidenced by lack of clinical signs of pseudorabies and lack of virus excretion. In contrast, pigs inoculated with strain Bartha or with the inactivated vaccine developed fever, had a period of growth arrest, and excreted virus after challenge exposure. In pigs without passively acquired antibody, intranasal inoculation with strains NIA-3 or Bartha was followed by primary IgM and IgA responses in serum and in oropharyngeal fluid as well as primary IgG1 and IgG2 responses in serum. Intramuscular inoculation with the inactivated vaccine induced primary serum IgM, IgG1, and IgG2 responses, but no mucosal responses. Challenge exposure of pigs that had been inoculated with the Bartha strain or the inactivated vaccine was followed by clear memory responses in serum and in oropharyngeal fluid. In contrast, challenge exposure of pigs that had been inoculated by the virulent NIA-3 strain was not followed by memory responses.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
19.
Intestinal antibody response after vaccination and infection with rotavirus of calves fed colostrum with or without rotavirus antibody 总被引：6，自引：0，他引：6
The intestinal and systemic antibody response of calves vaccinated and/or challenged with rotavirus was studied employing isotype-specific ELISAs for the detection of IgG1, IgG2, IgM and IgA antibodies to rotavirus. Monoclonal antibodies to bovine immunoglobulin isotypes of proven specificity were used as conjugated or catching antibody. Five days after oral inoculation (dpi) of a 5-day-old gnotobiotic calf with rotavirus, IgM rotavirus antibodies were excreted in faeces, followed 5 days later by IgA rotavirus antibodies. The increase in IgM rotavirus antibody titre coincided with the inability to detect further rotavirus excretion. Faeces IgM and IgA rotavirus antibody titres fell to low levels within 3 weeks post infection. IgG1 and IgG2 rotavirus antibodies were not detected in faecal samples. In serum, antibodies to rotavirus of all four isotypes were detected, starting with IgM at 5 dpi. Two SPF-calves, which were fed colostrum free of rotavirus antibodies, were vaccinated with a modified live rotavirus vaccine and challenged with virulent rotavirus 6 days later. Upon vaccination, the calves showed an antibody response similar to the response of the infected gnotobiotic calf. Intestinal IgM rotavirus antibodies were excreted before or on the day of challenge and appeared to be associated with protection against challenge infection with virulent virus and rotavirus-induced diarrhoea. In 3 control calves, which were challenged only, the antibody patterns also resembled that of the gnotobiotic calf and again the appearance of IgM rotavirus antibodies coincided with the end of the rotavirus detection period. Two other groups of 3 SPF-calves were treated similarly, but the calves were fed colostrum with rotavirus antibodies during the first 48 h of life. These calves excreted passively acquired IgG1 and IgG2 rotavirus antibodies in their faeces from 2 to 6 days after birth. After vaccination, no IgM or IgA antibody activity in serum or faeces was detectable. Upon challenge, all calves developed diarrhoea and excreted rotavirus. Seven to 10 days after challenge low levels of IgM rotavirus antibody were detected for a short period. These data indicate that the intestinal antibody response of young calves to an enteric viral infection is associated with the excretion of IgM antibodies, immediately followed by IgA antibodies. This response is absent or diminished in calves with passively acquired specific antibodies which may explain the failure to induce a protective intestinal immune response by oral vaccination with modified live rotavirus of calves fed colostrum containing rotavirus antibodies. 相似文献